Tmoyan N A, Ezhov M V, Afanasieva O I, Klesareva E A, Afanasieva M I, Balakhonova T V, Pokrovsky S N
National Medical Research Center of Cardiology, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3. Vyp. 2):42-48. doi: 10.17116/jnevro202012003242.
Lipoprotein(a) [Lp(a)] is a genetically determined risk factor of coronary heart disease and its complications. Meanwhile data about the role of Lp(a) in development of ischemic stroke are controversial.
To investigate the association of Lp(a) with atherothrombotic ischemic stroke and stenotic (≥50%) atherosclerosis of carotid arteries.
The study included 490 patients (mean age 60 years, 53% male). The first group comprised 157 patients with ischemic stroke, the second group 68 patients with isolated stenotic atherosclerosis of carotid arteries, but without significant lesion of coronary and low limbs arteries. The control group included 265 patients without stroke, myocardial infarction, stenotic atherosclerosis of coronary, carotid and low limbs arteries according to instrumental examinations. The levels of Lp(a) and lipids were measured in blood serum of all patients.
Lp(a) concentration was significantly higher in patients of the first and second groups in comparison with the control group (median [interquartile range]): 24 [9; 48], 20 [8; 55] vs 13 [5; 27] mg/dl, respectively (p<0,05 in both cases). Hyperlipoproteinemia(a) (Lp(a) ≥30 mg/dl) was more frequent in the group with stroke, stenotic atherosclerosis of carotid arteries, than in the control group: 43%, 40% vs 22% (p<0.01 in all cases). In patients with hyperlipoproteinemia(a), odds ratio (OR) for ischemic stroke was 2.7 (95% confidence interval (CI) 1.7-4.1), and OR for stenotic atherosclerosis of carotid arteries was 2.3 (95% CI 1.3-4.0) compared to the patients with Lp(a) level <30 mg/dl (p<0.01 in both cases). In logistic regression analysis adjusted for age, sex, hypertension, type 2 diabetes, smoking and Lp(a) concentration, the hyperlipoproteinemia(a) was associated with ischemic stroke and isolated stenotic carotid atherosclerosis. In the group with severe carotid atherosclerosis, 16 patients (24%) had ischemic stroke. Lp(a) concentration in these patients was higher 36 [20; 59] mg/dl, than in the patients with isolated carotid atherosclerosis without stroke 15 [7; 54] mg/dl (p=0.04). Other risk factors of atherosclerosis did not differ in patients with or without ischemic stroke.
The study shows the association of elevated level of Lp(a) with ischemic stroke and isolated stenotic atherosclerosis of carotid arteries. In the presence of isolated stenotic carotid atherosclerosis, the median of Lp(a) concentration was significantly higher in patients with ischemic stroke than in patients without stroke.
脂蛋白(a)[Lp(a)]是冠心病及其并发症的一种遗传决定风险因素。同时,关于Lp(a)在缺血性卒中发生中的作用的数据存在争议。
研究Lp(a)与动脉粥样硬化性血栓形成性缺血性卒中和颈动脉狭窄(≥50%)性动脉粥样硬化的关联。
该研究纳入了490例患者(平均年龄60岁,53%为男性)。第一组包括157例缺血性卒中患者,第二组包括68例孤立性颈动脉狭窄性动脉粥样硬化患者,但冠状动脉和下肢动脉无明显病变。对照组包括265例经仪器检查无卒中、心肌梗死、冠状动脉、颈动脉和下肢动脉狭窄性动脉粥样硬化的患者。测量了所有患者血清中的Lp(a)和血脂水平。
第一组和第二组患者的Lp(a)浓度显著高于对照组(中位数[四分位间距]):分别为24[9;48]、20[8;55]mg/dl,而对照组为13[5;27]mg/dl(两种情况均p<0.05)。卒中、颈动脉狭窄性动脉粥样硬化组的高脂蛋白血症(a)[Lp(a)≥30mg/dl]比对照组更常见:分别为43%、40%,而对照组为22%(所有情况均p<0.01)。与Lp(a)水平<30mg/dl的患者相比,高脂蛋白血症(a)患者发生缺血性卒中的比值比(OR)为2.7(95%置信区间(CI)1.7 - 4.1),发生颈动脉狭窄性动脉粥样硬化的OR为2.3(95%CI 1.3 - 4.0)(两种情况均p<0.01)。在对年龄、性别、高血压、2型糖尿病、吸烟和Lp(a)浓度进行校正的逻辑回归分析中,高脂蛋白血症(a)与缺血性卒中和孤立性颈动脉狭窄性动脉粥样硬化相关。在严重颈动脉粥样硬化组中,16例患者(24%)发生了缺血性卒中。这些患者的Lp(a)浓度为36[20;59]mg/dl,高于无卒中的孤立性颈动脉粥样硬化患者的15[7;54]mg/dl(p = 0.04)。有或无缺血性卒中的患者,其他动脉粥样硬化危险因素无差异。
该研究表明Lp(a)水平升高与缺血性卒中和孤立性颈动脉狭窄性动脉粥样硬化相关。在存在孤立性颈动脉狭窄性动脉粥样硬化的情况下,缺血性卒中患者的Lp(a)浓度中位数显著高于无卒中患者。